Search - tctmd.com

Displaying 621 - 640 of 1324

Sort: Relevancy | Date

Presentation TCT 2018

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Antonio L. Bartorelli, David G. Rizik, Michael Haude

September 21, 2018

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

Presentation TCT 2018

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Presenter: Jeroen J. Bax, Stephan Windecker, Javier Escaned

September 21, 2018

Presentation TCT 2018

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Presenter: Bernardo Cortese

September 21, 2018

Presentation TCT 2018

Novasight HybridTM A Novel Hybrid Intravascular Ultrasound and Optical Coherence Tomography Imaging System (Conavi Medical Inc.)

Presenter: Brian K Courtney

September 21, 2018

News Daily News

FDA Approves New Covered Stent Option for Coronary Perforations

Todd Neale

September 14, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

Michael O'Riordan

August 14, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Caitlin E. Cox

June 19, 2018

News Daily News

After Acute MI, 1 in 10 Patients Work Less or Stop Working Altogether

L.A. McKeown

June 14, 2018

News Daily News

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

L.A. McKeown

June 01, 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Industry News

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

May 24, 2018

Advertisement

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Novasight HybridTM A Novel Hybrid Intravascular Ultrasound and Optical Coherence Tomography Imaging System (Conavi Medical Inc.)

FDA Approves New Covered Stent Option for Coronary Perforations

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

After Acute MI, 1 in 10 Patients Work Less or Stop Working Altogether

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content